DEMLOVÁ, Regina, Radka OBERMANNOVÁ, Dalibor VALÍK a Rostislav VYZULA. Phase I Trial in Oncology – Theory and Practice. Klinická onkologie. Praha: Česká lékařská společnost J.E.Purkyně, 2012, roč. 2012, č. 2, s. 2S98- 2S101, 4 s. ISSN 0862-495X. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1087142, author = {Demlová, Regina and Obermannová, Radka and Valík, Dalibor and Vyzula, Rostislav}, article_location = {Praha}, article_number = {2}, keywords = {phase I trial; phase I unit; rule-based design; model based design; targeted therapy}, language = {eng}, issn = {0862-495X}, journal = {Klinická onkologie}, title = {Phase I Trial in Oncology – Theory and Practice}, volume = {2012}, year = {2012} }
TY - JOUR ID - 1087142 AU - Demlová, Regina - Obermannová, Radka - Valík, Dalibor - Vyzula, Rostislav PY - 2012 TI - Phase I Trial in Oncology – Theory and Practice JF - Klinická onkologie VL - 2012 IS - 2 SP - 2S98- 2S101 EP - 2S98- 2S101 PB - Česká lékařská společnost J.E.Purkyně SN - 0862495X KW - phase I trial KW - phase I unit KW - rule-based design KW - model based design KW - targeted therapy N2 - Phase I trials in oncology usually enrolling patients with advanced disease who have failed standard treatment options. The primary endpoint of these studies is to establish the recommended dose and/or schedule of new drugs or drug combinations for phase II trials. The guiding principle for dose escalation in phase I trials is to avoid unnecessary exposure of patients to sub-therapeutic doses of an agent. The mission of phase I clinical trials is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. ER -
DEMLOVÁ, Regina, Radka OBERMANNOVÁ, Dalibor VALÍK a Rostislav VYZULA. Phase I Trial in Oncology – Theory and Practice. \textit{Klinická onkologie}. Praha: Česká lékařská společnost J.E.Purkyně, 2012, roč.~2012, č.~2, s.~2S98- 2S101, 4 s. ISSN~0862-495X.
|